Dr. Wong is an infectious disease physician with an expertise in the management of complicated infections. Prior to joining USC-faculty, he received his training at tertiary university referral hospitals in both Philadelphia and New York City.
Dr. Wong’s current research is focused on examining empiric antibiotic therapy for sepsis. He has a particular focus on the management of multi-drug resistant bacterial infections and Clostridium difficile disease. Additionally, he is very committed to medical education and has significant teaching responsibilities for resident and fellow doctors-in-training. He is also actively involved in hospital infection control and antimicrobial stewardship, and the integration both programs to optimize clinical care.
Montefiore Medical Center: Leo M. Davidoff Society Award for Outstanding Achievement in Teaching, 2014
. View in: PubMed
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy. Drugs. 2017 Mar 16. View in: PubMed
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev. 2017 Jan; 30(1):409-447. View in: PubMed
Facklamia Species as an Underrecognized Pathogen. Open Forum Infect Dis. 2017; 4(1):ofw272. View in: PubMed
Leveraging Antimicrobial Stewardship into Improving Rates of Carbapenem-Resistant Enterobacteriaceae. Virulence. 2016 May 17; 0. View in: PubMed
Anti-NMDAR encephalitis, a mimicker of acute infectious encephalitis and a review of the literature. IDCases. 2014; 1(4):66-7. View in: PubMed